CytomX Therapeutics (CTMX) PT Raised to $16 at Jefferies: 'buying opportunity here'

March 18, 2026 10:16 AM

Jefferies analyst Roger Song raised the price target on CytomX Therapeutics (NASDAQ: CTMX) to $16.00 (from $8.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found